Superworth

CareDx EPS CDNA

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Sep 30, 2026
$2.39
Latest quarter, Q3 FY26
$0.35
+1067% on a year earlier
Fiscal year 2025
−$0.40
−148% on the year before

CareDx's earnings per share was $2.39 over the twelve months to Sep 30, 2026, up 101% on a year earlier.

In its latest quarter, Q3 FY26, it was $0.35, up 1067% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.40−148%
FY2024$0.84n/a
FY2023−$3.54n/a
FY2022−$1.44n/a
FY2021−$0.59n/a
FY2020−$0.42n/a
FY2019−$0.52n/a
FY2018−$1.33n/a
FY2017−$2.21n/a
FY2016−$2.57n/a
FY2015−$1.15n/a
FY2014−$1.04n/a
FY2013−$3.50n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26$0.35+1067%$2.39
Q2 FY26$2.07n/a$2.07
Q1 FY26$0.05n/a−$0.16
Q4 FY25−$0.08−105%−$0.40
Q3 FY25$0.03n/a$1.19
Q2 FY25−$0.16n/a$0.96
Q1 FY25−$0.19n/a$1.03
Q4 FY24$1.51n/a$0.84
Q3 FY24−$0.20n/a−$2.88
Q2 FY24−$0.09n/a−$3.11
Q1 FY24−$0.38n/a−$3.48
Q4 FY23−$2.21n/a−$3.54

Against its peers

Companies in Medical - Diagnostics & Research nearest CareDx's size, closest first, today.

CompanyEPS, 12 monthsGrowth
CDNACareDx$2.39+101% a year
VCYTVeracyte$1.40+324% a year
BLLNBillionToOne$0.65
LNTHLantheus$4.13+10% a year
CAICaris Life Sciences$0.37
BIOBio-Rad Laboratories$8.25−30% a year
RVTYRevvity$2.10−11% a year
MEDPMedpace$17.05+27% a year
DGXQuest Diagnostics$10.03+18% a year
LHLabcorp$12.09+33% a year
MTDMettler-Toledo International$44.42+12% a year
Peer median$6.19

Where CareDx ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on CareDx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.